Prolonged exposure to high level of estrogen is a known risk factor for breast carcinogenesis. In cells, estrogens, in particular estrone (E 1 ) and 17b b-estradiol (E 2 ), can be converted to catecholestrogens (CEs) which may be oxidized to form CE-semiquinones and CE-quinones that are capable of binding to DNA to induce mutations, followed by carcinogenesis. Whether the body is equipped with protective mechanisms against potentially harmful CEs, therefore, is an important issue. The present study was designed to examine the role of sulfation in the metabolism of CEs. MCF-7 breast cancer cells and MCF 10A human mammary epithelial cells were metabolically labeled with [ 
Estrogen-dependent carcinogenesis may arise from receptormediated events that stimulate cellular proliferation and promote tumor progression. [4] [5] [6] Additionally, estrogens may be hydroxylated to form catecholestrogens (CEs) which then undergo further metabolism to form CE-semiquinones and CE-quinones that are capable of binding to DNA to induce mutations, followed by carcinogenesis. 7, 8) Whether the human body is equipped with protective mechanisms against potentially harmful CEs, therefore, is an important issue.
Sulfate conjugation is a major pathway in mammals for the biotransformation and excretion of drugs/xenobiotics as well as the homeostasis of endogenous compounds such as steroid and thyroid hormones, catecholamines, cholesterol, and bile acids. [9] [10] [11] The responsible enzymes, called the "cytosolic sulfotransferases (SULTs)'', catalyze the transfer of a sulfonate group from the active sulfate, 3Ј-phosphoadenosine 5Ј-phosphosulfate (PAPS), to an acceptor substrate compound containing a hydroxyl or an amino group. 12) Sulfate conjugation by these enzymes may result in the inactivation (or, in some cases, activation) of the substrate compounds and/or increase their water-solubility, thereby facilitating their removal from the body. [9] [10] [11] In human body, several SULTs, including SULT1A1, SULT1A2, SULT1A3, SULT1C4, SULT1E1, and SULT2A1, have been shown to display sulfating activities toward the two major estrogens, estrone (E 1 ) and 17b-estradiol (E 2 ). 13, 14) Interestingly, studies have revealed that normal mammary epithelial cells contain predominantly SULT1E1 which has a K m in the nM range for estrogen and may thus metabolize it at lower thresholds. Whereas in MCF-7 breast cancer cells, SULT1E1 seems absent and appears to be replaced by SULT1A1 which has a K m in the mM range for estrogens and may only metabolize them at higher levels. 15) For CEs, their sulfation by purified human SULTs has also been reported. 16) Whether the sulfation of CEs occurs under metabolic conditions, however, remains to be clarified. Previous studies have demonstrated methylation as quantitatively the most prevalent conjugative pathway for CEs. 13, 17) Methylation of CEs is mediated by catechol-O-methyltransferase (COMT), a classical Phase II enzyme. Several epidemiological studies have shown that individuals with low activity form of COMT may have a greater risk for breast cancer, while contradictory results have also been reported. [18] [19] [20] [21] [22] It is noted that methylation of CEs is not an irreversible reaction. Previous studies have demonstrated the demethylation of methylated CEs (methoxyestrogens; MEs) both in vitro and in vivo. 23, 24) It is possible that the controversy over the genetic polymorphisms of COMT as a risk factor for breast cancer may be explained by the involvement of additional genes encoding, for example, SULTs that are also involved in the metabolism of CEs. 16) We report in this communication a metabolic study on the sulfation of CEs using MCF-7 breast cancer cells and MCF 10A non-tumorigenic human mammary epithelial cells. Results revealed a concerted action of methylation and sulfation in the metabolism of CEs. A systematic analysis of the sulfating activities of eleven known human SULTs toward CEs and MEs was carried out. 2 atmosphere at 37°C, in, respectively, MEM supplemented with 10% fetal bovine serum, penicillin G (30 mg/ml), and streptomycin sulfate (50 mg/ml) and MEGM. Confluent MCF-7 or MCF 10A cells grown in individual wells of a 24-well culture plate, preincubated in sulfate-free (prepared by omitting streptomycin sulfate and replacing magnesium sulfate with magnesium chloride) MEM for four hours, were labeled with 0.25 ml aliquots of the same medium containing [
MATERIALS AND METHODS

Materials
35 S]sulfate (0.3 mCi/ml), and 1 mM of CE, without or with tropolone (concentrations ranging from 50 mM to 1 mM), an inhibitor for COMT. At the end of a 21-h labeling, the media were collected and spin-filtered. The filtrates were subjected to the analysis of [
35 S]sulfated products using the previously established thin-layer electrophoresis (TLE) procedure, 26) with 5% acetic acid/0.5% pyridine (pH 3.5) as the electrophoresis buffer. After electrophoresis, an autoradiograph was taken from the TLC plate used for the analysis to reveal radioactive spots corresponding to [ 35 S]sulfated metabolites of CEs added to the labeling media.
Preparation of Purified Human SULTs Recombinant human P-form (SULT1A1 and SULT1A2) and M-form (SULT1A3) phenol SULTs, thyroid hormone SULT (SULT1B2), two SULT1Cs (SULT1C2 and SULT1C4), estrogen SULT (SULT1E1), dehydroepiandrosterone (DHEA) SULT (SULT2A1), two SULT2B1s (designated a and b), and a neuronal SULT (SULT4A1), expressed using pGEX-2TK or pET23c prokaryotic expression system, were prepared as previously described. [27] [28] [29] [30] Enzymatic Assay The sulfating activity of the recombinant human SULTs was assayed using PAP[ Control with DMSO alone was also prepared. The reaction was started by the addition of the enzyme (1.25 mg), allowed to proceed for 10 min at 37°C, and stopped by placing the assay mixture-containing thin-wall tube on a heating block, pre-heated to 100°C, for 2 min. The precipitates were cleared by centrifugation for 1 min, and the supernatant was subjected to the analysis of [ 35 S]sulfated 2-methoxy-E 2 might have been due to the decreased viability and, therefore, sulfating capacity of cells labeled in the presence of increasing concentrations of tropolone and sulfated 2-OH-E 2 generated under the experimental conditions. Collectively, the above-mentioned findings indicated that in MCF-7 and MCF 10A cells, a population of 4-OH-E 1 was methylated under the action of COMT prior to being subjected to sulfation. Whereas in these cells, 2-OH-E 1 and 2-or 4-OH-E 2 were nearly quantitatively methylated before being subjected to sulfation. While the functional relevance awaits further clarification, such double conjugation, as mediated by 35 S]sulfate in media containing 1 mM of 2-OH-E 2 plus varying concentrations of tropolone (0 mM, 50 mM, 400 mM, 250 mM, 500 mM, or 1 mM). At the end of a 21-h labeling, the labeling media were collected and subjected to TLE analysis for [
35 S]sulfated products. The figure shows the autoradiograph taken from the TLC plate used for the TLE analysis. Lane 1 corresponds to enzymatically synthesized [
35 S]sulfated 2-OH-E 2 . Lane 2 corresponds to a control labeling medium without 2-OH-E 2 . Lanes 3-8 correspond to labeling media containing 1 mM 2-OH-E 2 and 0 mM, 50 mM, 400 mM, 250 mM, 500 mM, and 1 mM of tropolone. Lane 9 corresponds to enzymatically synthesized Differential Sulfating Activities of the Human SULTs toward CEs and MEs Attempts were made to identify the SULT enzyme(s) that are capable of sulfating CEs and MEs. We have previously cloned, expressed, and purified eleven known human SULTs: SULT1A1, SULT1A2, SULT1A3, SULT1B2, SULT1C2, SULT1C4, SULT1E1, SULT2A1, SULT2B1a SULT2B1b, and SULT4A1. [27] [28] [29] [30] These purified recombinant human SULTs were examined for sulfating activities toward CEs and MEs under assay conditions described in Materials and Methods. Autoradiographs taken from the TLC plates used for the analysis of final assay mixtures revealed single radioactive spots corresponding the [
35 S]sulfated products of CEs or MEs tested as substrates. Activity data compiled in Table 1 showed that five (SULT1B2, SULT1C2, SULT2B1a, SULT2B1b and SULT4A1) of the eleven SULTs displayed no detectable activities. The other six human SULTs (SULT1A1, SULT1A2, SULT1A3, SULT1C4, SULT1E1 and SULT2A1) exhibited differential sulfating activities toward the different CEs and MEs. Among these latter enzymes, SULT1E1 displayed consistently strong activities toward all the compounds tested as substrates. It therefore appears that SULT1E1, which is known to be involved in the homeostasis of estrogens in estrogen-responsive tissues, may also serve to counteract the potentially harmful CEs and their methylated products, MEs. For the other five SULTs that showed CE/ME-sulfating activities, it is possible that they may also act locally in a tissuespecific manner to detoxify endogenous, and possibly xenobiotic, CEs and MEs and facilitate their removal from the body. Another possibility that should be considered is that, while sulfation of CEs and MEs may lead to their own inactivation and disposal, it may at the same time suppress the sulfation of estrogens, among other compounds, which in turn may lead to their prolonged existence (in unsulfated state) and estrogenic action.
In conclusion, the current study clearly demonstrated the occurrence of the sulfation of CEs and MEs in MCF-7 and MCF 10A cells and shows that SULT1E1 and five other human SULTs are capable of sulfating these potentially harmful compounds. From the physiology standpoint, the fact that sulfated CEs and MEs were generated and released by cultured cells suggests a concerted action of COMT and SULT enzymes in the metabolism and detoxification of these compounds in vivo. More work is warranted in order to fully elucidate these important issues. a) Specific activity refers to nmol substrate sulfated/min/mg purified enzyme. Data represent meanϮS.D. derived from three determinations. The concentration of estrone (E 1 ) or 17b-estradiol (E 2 ) tested as substrate was 1 mM, and the concentration of CE or ME tested as substrates was 5 mM. b) ND refers to activity not detected. Specific activity determined was lower than the detection limit (estimated to be ca. 0.01 nmol/min/mg protein).
